Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Complications, Compliance, and 3-Year Outcomes After Endolaserless Vitrectomy With Aflibercept Monotherapy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: February 13, 2023
Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
Journal: JAMA ophthalmology
Published: April 28, 2017
Ranibizumab 0.3 mg for Persistent Diabetic Macular Edema After Recent, Frequent, and Chronic Bevacizumab: The ROTATE Trial.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: July 08, 2016
Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy in a Predominantly Non-Asian Population: RIVAL Results.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: July 07, 2016
Intravitreal ranibizumab for polypoidal choroidal vasculopathy in non-Asian patients.
Journal: Retina (Philadelphia, Pa.)
Published: September 20, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026